Mereo Biopharma Group Plc (MAH0) Income Statement
Mereo Biopharma Group Plc Income Statement
Last quarter (Q2 2026), Mereo Biopharma Group Plc's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q2, Mereo Biopharma Group Plc's net income was $-7.00M. See Mereo Biopharma Group Plc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 500.00K | $ 0.00 | $ 10.00M | $ 0.00 | $ 49.21M | |
| $ 367.00K | $ 0.00 | $ 7.43M | $ 1.15M | $ 25.04M | |
| $ 38.62M | $ 0.00 | $ 35.84M | $ 55.57M | $ 53.30M | |
| Depreciation and Amortization | $ 1.15M | $ 1.09M | $ 1.06M | $ 889.00K | $ 866.47K |
| $ -40.47M | $ 1.09M | $ -26.06M | $ -37.87M | $ 25.49M | |
| $ -38.26M | $ 0.00 | $ -28.42M | $ -54.43M | ― | |
| $ -3.62M | $ 0.00 | $ -1.58M | $ 11.49M | $ 47.48M | |
| $ -41.88M | $ 0.00 | $ -30.00M | $ -42.94M | $ 19.22M | |
| $ -41.88M | $ 0.00 | $ -29.47M | $ -42.22M | $ 17.17M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.26 | $ 0.00 | $ -1100.22 | $ -1.80 | $ 749.65 |
| Diluted EPS | $ -0.26 | $ 0.00 | $ -1100.22 | $ -1.80 | $ 749.65 |
| Weighted Average Shares Outstanding | 159.42M | 29.58M | 131.89M | 22.80M | 116.73M |
| Weighted Average Shares Outstanding (Diluted) | 159.42M | 29.58M | 131.89M | 22.80M | 116.73M |
Currency in USD